DE69523759T2 - Zubereitungen der nervonsäure - Google Patents

Zubereitungen der nervonsäure

Info

Publication number
DE69523759T2
DE69523759T2 DE69523759T DE69523759T DE69523759T2 DE 69523759 T2 DE69523759 T2 DE 69523759T2 DE 69523759 T DE69523759 T DE 69523759T DE 69523759 T DE69523759 T DE 69523759T DE 69523759 T2 DE69523759 T2 DE 69523759T2
Authority
DE
Germany
Prior art keywords
nervonic acid
pct
functional derivative
women
date feb
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69523759T
Other languages
English (en)
Other versions
DE69523759T3 (de
DE69523759D1 (de
Inventor
Keith Coupland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Croda International PLC
Original Assignee
Croda International PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10760143&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69523759(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Croda International PLC filed Critical Croda International PLC
Application granted granted Critical
Publication of DE69523759D1 publication Critical patent/DE69523759D1/de
Publication of DE69523759T2 publication Critical patent/DE69523759T2/de
Publication of DE69523759T3 publication Critical patent/DE69523759T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69523759T 1994-08-19 1995-08-21 Zubereitungen der nervonsäure Expired - Lifetime DE69523759T3 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9416846 1994-08-19
GB9416846A GB9416846D0 (en) 1994-08-19 1994-08-19 Lipid supplementation
PCT/GB1995/001985 WO1996005740A1 (en) 1994-08-19 1995-08-21 Nervonic acid compositions

Publications (3)

Publication Number Publication Date
DE69523759D1 DE69523759D1 (de) 2001-12-13
DE69523759T2 true DE69523759T2 (de) 2002-08-01
DE69523759T3 DE69523759T3 (de) 2005-12-01

Family

ID=10760143

Family Applications (2)

Application Number Title Priority Date Filing Date
DE0769917T Pending DE769917T1 (de) 1994-08-19 1995-08-21 Zubereitungen der nervonsäure
DE69523759T Expired - Lifetime DE69523759T3 (de) 1994-08-19 1995-08-21 Zubereitungen der nervonsäure

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE0769917T Pending DE769917T1 (de) 1994-08-19 1995-08-21 Zubereitungen der nervonsäure

Country Status (8)

Country Link
US (1) US5994404A (de)
EP (1) EP0769917B2 (de)
JP (2) JP3614859B2 (de)
AT (1) ATE208143T1 (de)
CA (1) CA2196880C (de)
DE (2) DE769917T1 (de)
GB (1) GB9416846D0 (de)
WO (1) WO1996005740A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001278786A (ja) * 2000-03-29 2001-10-10 Morinaga Milk Ind Co Ltd 高尿酸性疾患予防治療剤
US6511696B2 (en) * 2000-12-13 2003-01-28 Novartis Nutrition Ag Infant formula with free amino acids and nucleotides
GB0112324D0 (en) * 2001-05-21 2001-07-11 Croda Int Plc Compounds
US7704542B2 (en) * 2001-09-12 2010-04-27 Xanodyne Pharmaceuticals, Inc. Vitamin/mineral compositions with DHA
US6949586B2 (en) * 2002-02-11 2005-09-27 Council Of Scientific Research Synergistic composition of trans-tetracos-15-enoic acid and Apocynin and method of treatment for hepatotoxicity
US20030228392A1 (en) * 2002-06-06 2003-12-11 Wyeth Infant formula compositions containing lutein and zeaxanthin
EP1402786A1 (de) * 2002-09-27 2004-03-31 Loders Croklaan B.V. Ximenynsäure
EP1402787A1 (de) * 2002-09-27 2004-03-31 Loders Croklaan B.V. Ximeninsäure
EP1402785A1 (de) * 2002-09-27 2004-03-31 Loders Croklaan B.V. Ximeninsäure
US7635168B2 (en) * 2006-08-11 2009-12-22 Hall David R Degradation assembly shield
US8269062B2 (en) 2006-11-21 2012-09-18 National Research Council Of Canada Lunaria annua, Cardamine graeca and Teesdalia nudicaulis FAE genes and their use in producing nervonic and eicosenoic acids in seed oils
MX2018008520A (es) * 2016-03-30 2018-08-16 Nestec Sa Composiciones que comprenden acidos grasos y su uso.
CN112544979A (zh) * 2020-12-11 2021-03-26 广西科技大学 蒜头果油微胶囊的乳化工艺
CN113455649B (zh) * 2021-06-23 2022-08-02 湖南万象生物科技有限公司 一种含有神经酸和α-亚麻酸的组合物、水溶性粉剂及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58198245A (ja) * 1982-05-13 1983-11-18 Fuji Oil Co Ltd 製菓用油脂のグレイニング防止法
JPS61209544A (ja) * 1985-03-14 1986-09-17 Ueda Seiyu Kk 人乳脂類似油脂
DE3715424C2 (de) * 1987-05-08 1995-01-26 Henkel Kgaa Verwendung eines fetten Öles aus Helianthus annuus zur Herstellung von Fettsäure-Monoglyceriden
FR2623692B1 (fr) * 1987-11-30 1991-05-03 Vernin Jean Gilles Nouvelle huile dietetique
GB8804188D0 (en) * 1988-02-23 1988-03-23 Croda Int Plc Pharmaceutical compositions
US5190783A (en) * 1989-09-19 1993-03-02 Nabisco, Inc. Primary amide esters as low calorie fat mimetics
US5411756A (en) * 1989-09-20 1995-05-02 Nabisco, Inc. Reduced calorie triglyceride mixtures
US5194448A (en) * 1989-11-30 1993-03-16 Croda International Plc Use of nervonic acid and long chain fatty acids for the treatment of demyelinating disorders
JP2911526B2 (ja) * 1990-02-23 1999-06-23 森永乳業株式会社 乳幼児食品用油脂組成物
US5043179A (en) * 1990-03-29 1991-08-27 Nabisco Brands, Inc. Triol triester derivatives as low calorie fat mimetics
JP2943031B2 (ja) * 1991-11-30 1999-08-30 株式会社ホーネンコーポレーション 天然ビタミンｋ濃縮物の製造方法

Also Published As

Publication number Publication date
DE69523759T3 (de) 2005-12-01
US5994404A (en) 1999-11-30
EP0769917B1 (de) 2001-11-07
CA2196880A1 (en) 1996-02-29
DE769917T1 (de) 1999-12-09
WO1996005740A1 (en) 1996-02-29
JPH10507623A (ja) 1998-07-28
AU711302B2 (en) 1999-10-07
AU3262895A (en) 1996-03-14
EP0769917B2 (de) 2005-03-16
JP2005002119A (ja) 2005-01-06
EP0769917A1 (de) 1997-05-02
JP3614859B2 (ja) 2005-01-26
GB9416846D0 (en) 1994-10-12
ATE208143T1 (de) 2001-11-15
CA2196880C (en) 2006-10-17
DE69523759D1 (de) 2001-12-13

Similar Documents

Publication Publication Date Title
ATE208143T1 (de) Zubereitungen der nervonsäure
Carlsson et al. Early establishment of Streptococcus salivarius in the mouths of infants
MY122501A (en) Lactobacilli to increase absorption of minerals by intestinal cells
NZ514164A (en) Powdered human milk fortifier comprising 24%-55% protein, 1%-30% fat and 15%-75% carbohydrate plus an emulsifier
DE3477733D1 (en) Two-phase formulation
HK120497A (en) Use of C-22 to C-26 aliphatic alcohols in the treatment of inflammatory and viral skin diseases
GR3021890T3 (en) Use of thiazolidine-4-carboxylate derivatives for the treatment of pulmonary diseases
US5591446A (en) Methods and agents for the prophylaxis of atopy
EP2450044A1 (de) Difructoseanhydridhaltige Zusammensetzung zur Vermeidung von Zahnkaries
HUT47221A (en) Process for production of medical compositions containing as active substance human xiii factor
Abdullah Traditional practices and other socio-cultural factors affecting the health of children in Saudi Arabia
JP2000245391A (ja) 健康食品
FR2811204A1 (fr) Composition d'un complement nutritionnel et polyactif
EP0238198A3 (de) Verfahren zur Abänderung der Lipid-Struktur-Funktion und von Zellmembranen und pharmazeutische Zusammensetzungen zur Verwendung dabei
Morris Use of vitamin C in acne vulgaris
MX9803565A (es) Metodo para inhibir la union de h, influenzae a celulas humanas utilizando beta-caseina humana, fosforilada, recombinante.
Zahorsky The Semeiology of the Pink Disease (Erythredema, Acrodynia): Report of Four Cases
Larson et al. Effect of administration of EDTA by various routes on dental caries in the rat: Possible role of coprophagy
JP2000069935A (ja) アトピー性皮膚炎を防ぐ保健食品
Chen Guest editorial: breast feeding and hospital practices
McKinney et al. Common dentally related nutrition concerns of children with special needs: Part 1
TOLENTINO Purpura Fulminans
RO86113B1 (ro) Sirop antianemic
ROBINSON et al. ON COMMENTS BY DR. DIAMOND ET AL
WO1994008474A3 (en) Medical food and method of administration

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings